Hill-Rom Holdings Inc (HRC) is a publicly traded medical instruments and supplies business based in the US which employs around 10,000 staff. Hill-Rom Holdings is listed on the NYSE and traded in US dollars.
How to buy shares in Hill-Rom Holdings
Open a brokerage account.Choose from our top broker picks or compare brokers in depth. To trade US shares you'll need to complete a W8-BEN form – typically part of the sign-up process.
Fund your account.Add money to your account via bank transfer or debit card.
Search the platform by ticker symbol.HRC in this case.
Choose an order type.Place a market order (or limit order, if you want to try to hold out for a specific price) with your preferred number of shares or investment amount.
Submit the order.It's that simple.
The whole process can take as little as 15 minutes. You'll need a smartphone or computer, an internet connection, your passport or driving licence and a means of payment.
Our top picks for where to buy Hill-Rom Holdings shares
We analysed all popular share dealing platforms in the UK using 35 data points and combined this with our expert insight from using the apps. The platforms we've selected as best for each category offer stand-out features or a unique combination of elements for a specific aspect of investing. If we show a "Promoted for" pick, it's been chosen from among our partners and is based on factors that include special features or offers, and the commission we receive. Keep in mind that our picks may not always be the best for you – it's important to compare for yourself. More details in our full methodology.
Hill-Rom Holdings stock chart
Use our graph to track the performance of HRC stock over time.
These providers cover a wide range of stocks, but we can't guarantee they'll all offer this stock.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Boost your investment IQ!
Subscribe now for market insights, expert advice and a chance to win £400! (T&Cs)
The gauge below shows real-time ratings that are based on 26 popular indicators such as moving averages, for specific time periods. It's not a recommendation but is simply technical analysis that can form part of your research.
Finder might not agree with the analysis and we take no responsibility. We also give no representations or warranty on the accuracy or completeness of the information provided on this page.
All investing should be regarded as longer term. The value of your investments can go up and down, and you may get back less than you invest. Past performance is no guarantee of future results. If you’re not sure which investments are right for you, please seek out a financial adviser. Capital at risk.
Is Hill-Rom Holdings under- or over-valued?
Valuing a stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of overall performance. However, analysts commonly use some key metrics to help gauge value. Check out the Hill-Rom Holdings P/E ratio, PEG ratio and EBITDA.
Hill-Rom Holdings's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 42x. In other words, Hill-Rom Holdings's shares trade at around 42x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the United States stock markets on average as of March 2025 (25.37). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Hill-Rom Holdings's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.71. A PEG ratio over 1 can be interpreted as meaning shares are overvalued at the current rate of growth, or may anticipate an acceleration in growth.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Hill-Rom Holdings's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Hill-Rom Holdings's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $645.3 million (£476 million).
The EBITDA is a measure of Hill-Rom Holdings's overall financial performance and is widely used to measure a its profitability.
Forward annual dividend yield: 0.62% of stock value
Dividend payout ratio: 15.21% of net profits
Hill-Rom Holdings has recently paid out dividends equivalent to 0.62% of its share value annually.
Hill-Rom Holdings has paid out, on average, around 15.21% of recent net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.62% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), shareholders could enjoy a 0.62% return on their shares, in the form of dividend payments. In Hill-Rom Holdings's case, that would currently equate to about 0.94 per share.
While Hill-Rom Holdings's payout ratio might seem low, this can signify that the company is investing more in its future growth.
Hill-Rom Holdings's most recent dividend payout was on 30 December 2021. To be eligible for the latest dividend you would need to have been a shareholder at 13 December 2021 (the "ex-dividend date").
Currently 0.18% of Hill-Rom Holdings shares are held by insiders and 84.381% by institutions.
Hill-Rom Holdings's fiscal year ends in September.
Hill-Rom Holdings's address is: 130 East Randolph Street, Chicago, IL, United States, 60601
Hill-Rom Holdings's shares were split on a 2:1 basis on 1 March 1992. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Hill-Rom Holdings shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Hill-Rom Holdings shares which in turn could have impacted Hill-Rom Holdings's share price.
It's as easy to sell Hill-Rom Holdings as it is to buy! Here's how to sell Hill-Rom Holdings shares that you already own.
Open your investment app. If you've got one with desktop access, you can log in online
Go to your portfolio. This should be in the main menu
Find your shares. You may be able to search your portfolio
Choose how many you'd like to sell. You'll be able to review the price and see how much you'll receive
Sell your Hill-Rom Holdings shares. Your investment platform will let you know when your shares are sold
Most dealing providers will let you use your debit card to top up your account and buy shares. The main ways are with a debit card, bank transfer or with Apple/Google Pay.
The easiest way to get hold of some Hill-Rom Holdings shares is to sign up for a share trading app and place a market order or basic order. This type of order tells the platform that you're interested, so it'll try to execute it as quickly as it can. It could take some time for the order to go through, especially if there's a lot of volatility in Hill-Rom Holdings shares.
Yes. When you investing in a US stock, you need to complete a W8-BEN form to minimise your tax liability. Whether these are automatically handled for you depends on your broker, so it would be a good idea to check with them directly.
Mental health stocks can be rewarding, but there are risks involved that could impact your profits. Find out how to invest in companies in the mental health industry.
Ever wondered how to buy shares in Curaleaf Holdings? We explain how and compare a range of providers that can give you access to many brands, including Curaleaf Holdings.
Ever wondered how to buy shares in Aurora Cannabis? We explain how and compare a range of providers that can give you access to many brands, including Aurora Cannabis.
Ever wondered how to buy shares in Walgreens? We explain how and compare a range of providers that can give you access to many brands, including Walgreens.
Ever wondered how to buy shares in Medtronic? We explain how and compare a range of providers that can give you access to many brands, including Medtronic.
Ever wondered how to buy shares in AstraZeneca? We explain how and compare a range of providers that can give you access to many brands, including AstraZeneca.
Learn more about GSK’s recent performance and where you can buy GSK shares. We also run through a helpful checklist for anyone looking to invest.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.